Metformin has proven to be a “magic drug” beyond its application in treating diabetes. Over the past 20 years, metformin has become the mainstay of type 2 diabetes treatment and […]
The top spot in the world’s best-selling drug list may not be a suspense in the short term, according to a report by EvaluatePharma, a market research firm. In 2018, […]
Olaparib, also known as AZD-2281 or KU-59436, is a small molecule inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to […]